Rhythm Pharmaceuticals Receives $21,000,000 Series A Funding Round

  • Feed Type
  • Date
    3/15/2010
  • Company Name
    Rhythm Pharmaceuticals
  • Mailing Address
    Undisclosed Boston, MA 02101
  • Company Description
    Rhythm is a biotechnology company developing peptide therapeutics that address unmet needs in metabolic diseases.
  • Website
    http://www.rhythmtx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $21,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    The funds will be used to develop products licensed from Ipsen (Euronext: IPN).
  • M&A Terms
  • Venture Investor
    MPM Capital
  • Venture Investor
    New Enterprise Associates

By posting a comment, you agree to our terms and conditions.